These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1151 related items for PubMed ID: 26718510

  • 1. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG, Doshi D, Mack MJ, Makkar R, Smith CR, Pichard AD, Kodali S, Kapadia S, Miller DC, Babaliaros V, Thourani V, Herrmann HC, Bodenhamer M, Whisenant BK, Ramee S, Maniar H, Kereiakes D, Xu K, Jaber WA, Menon V, Tuzcu EM, Wood D, Svensson LG, Leon MB.
    JACC Cardiovasc Interv; 2015 Dec 21; 8(14):1797-806. PubMed ID: 26718510
    [Abstract] [Full Text] [Related]

  • 2. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A.
    JACC Cardiovasc Interv; 2015 Apr 27; 8(5):657-69. PubMed ID: 25946437
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial.
    Makkar RR, Cheng W, Waksman R, Satler LF, Chakravarty T, Groh M, Abernethy W, Russo MJ, Heimansohn D, Hermiller J, Worthley S, Chehab B, Cunningham M, Matthews R, Ramana RK, Yong G, Ruiz CE, Chen C, Asch FM, Nakamura M, Jilaihawi H, Sharma R, Yoon SH, Pichard AD, Kapadia S, Reardon MJ, Bhatt DL, Fontana GP.
    Lancet; 2020 Sep 05; 396(10252):669-683. PubMed ID: 32593323
    [Abstract] [Full Text] [Related]

  • 5. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P, Cohen DJ, Williams MR, Mack M, Kodali SK, Svensson LG, Kirtane AJ, Xu K, McAndrew TC, Makkar R, Smith CR, Leon MB.
    J Am Coll Cardiol; 2014 Mar 25; 63(11):1100-9. PubMed ID: 24291283
    [Abstract] [Full Text] [Related]

  • 6. One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Herrmann HC, Thourani VH, Kodali SK, Makkar RR, Szeto WY, Anwaruddin S, Desai N, Lim S, Malaisrie SC, Kereiakes DJ, Ramee S, Greason KL, Kapadia S, Babaliaros V, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Whisenant BK, Webb JG, Mack MJ, Leon MB, PARTNER Investigators.
    Circulation; 2016 Jul 12; 134(2):130-40. PubMed ID: 27400898
    [Abstract] [Full Text] [Related]

  • 7. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
    Mas-Peiro S, Seppelt PC, Weiler H, Mohr GL, Papadopoulos N, Walther T, Zeiher AM, Fichtlscherer S, Vasa-Nicotera M.
    J Invasive Cardiol; 2019 Jul 12; 31(7):E199-E204. PubMed ID: 31257214
    [Abstract] [Full Text] [Related]

  • 8. Commercial versus PARTNER study experience with the transfemoral Edwards SAPIEN valve for inoperable patients with severe aortic stenosis.
    Pendyala LK, Minha S, Barbash IM, Torguson R, Magalhaes MA, Okubagzi P, Loh JP, Chen F, Satler LF, Pichard AD, Waksman R.
    Am J Cardiol; 2014 Jan 15; 113(2):342-7. PubMed ID: 24220281
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
    Pibarot P, Hahn RT, Weissman NJ, Arsenault M, Beaudoin J, Bernier M, Dahou A, Khalique OK, Asch FM, Toubal O, Leipsic J, Blanke P, Zhang F, Parvataneni R, Alu M, Herrmann H, Makkar R, Mack M, Smalling R, Leon M, Thourani VH, Kodali S.
    JAMA Cardiol; 2017 Nov 01; 2(11):1208-1216. PubMed ID: 28973091
    [Abstract] [Full Text] [Related]

  • 11. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T, Castro-Filho A, Meneguz-Moreno RA, Siqueira DA, Abizaid AAC, Ramos AIO, Arrais M, Le Bihan DCS, Barretto RBM, Moreira AC, Sousa AGMR, Eduardo Sousa J.
    Catheter Cardiovasc Interv; 2017 Jul 01; 90(1):139-146. PubMed ID: 28029207
    [Abstract] [Full Text] [Related]

  • 12. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O, Pellegrini C, Kessler T, Burgdorf C, Thaller H, Mayr NP, Ott I, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C.
    JACC Cardiovasc Interv; 2015 Dec 21; 8(14):1809-16. PubMed ID: 26718512
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ, Thourani VH, Kodali S, Arnold SV, Wang K, Magnuson EA, Pichard AD, Babaliaros V, George I, Miller DC, Tuzcu EM, Greason K, Herrmann HC, Smith CR, Leon MB, Cohen DJ, PARTNER 2 InvestigatorsSaint Luke's Mid America Heart Institute, Kansas City, Missouri..
    JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1188-1198. PubMed ID: 29860075
    [Abstract] [Full Text] [Related]

  • 16. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M, Neumann FJ, Mehilli J, Frerker C, Richardt D, Landt M, Jose J, Toelg R, Kuck KH, Massberg S, Robinson DR, El-Mawardy M, Richardt G, CHOICE Investigators.
    J Am Coll Cardiol; 2015 Aug 18; 66(7):791-800. PubMed ID: 26271061
    [Abstract] [Full Text] [Related]

  • 17. Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves.
    Binder RK, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Pedrazzini G, Amann FW, Ferrari E, Noble S, Nietlispach F, Maisano F, Räber L, Roffi M, Grünenfelder J, Jüni P, Huber C, Windecker S, Wenaweser P.
    Circ Cardiovasc Interv; 2015 Oct 18; 8(10):. PubMed ID: 26453687
    [Abstract] [Full Text] [Related]

  • 18. Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry.
    Fearon WF, Kodali S, Doshi D, Fischbein MP, Yeung AC, Tuzcu EM, Rihal CS, Babaliaros V, Zajarias A, Herrmann HC, Brown DL, Mack M, Teirstein PS, Whisenant BK, Makkar R, Kapadia S, Leon MB, PARTNER Trial Investigators.
    JACC Cardiovasc Interv; 2014 Nov 18; 7(11):1245-51. PubMed ID: 25459036
    [Abstract] [Full Text] [Related]

  • 19. Transaortic transcatheter aortic valve implantation: experience from the Kiel study.
    Petzina R, Lutter G, Wolf C, Kühl C, Freitag-Wolf S, Panholzer B, Bramlage P, Frey N, Cremer J, Frank D.
    Interact Cardiovasc Thorac Surg; 2017 Jan 18; 24(1):55-62. PubMed ID: 27600910
    [Abstract] [Full Text] [Related]

  • 20. Computed Tomography-Based Oversizing Degrees and Incidence of Paravalvular Regurgitation of a New Generation Transcatheter Heart Valve.
    Blanke P, Pibarot P, Hahn R, Weissman N, Kodali S, Thourani V, Parvataneni R, Dvir D, Naoum C, Nørgaard BL, Douglas P, Jaber W, Khalique OK, Jilaihawi H, Mack M, Smith C, Leon M, Webb J, Leipsic J.
    JACC Cardiovasc Interv; 2017 Apr 24; 10(8):810-820. PubMed ID: 28427598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.